NCT05195762 2024-05-28
12-week Study of NFX-179 Gel in Subjects With Epidermal Nevi
Stanford University
Phase 2 Withdrawn
Clinical Trials
5 trialsNCT02304367 2024-05-06
Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)
Kyowa Kirin Co., Ltd.
Phase 2 Completed
NCT04320316 2022-10-07
ENS
University of Alabama at Birmingham
Phase 4 Completed
NCT02722798 2022-09-06
A Study of KRN23 in Subjects With Tumor-Induced Osteomalacia or Epidermal Nevus Syndrome
Kyowa Kirin Co., Ltd.
Phase 2 Completed
NCT03993821 2022-03-07
Burosumab for CSHS
Children's National Research Institute
Phase EARLY_PHASE1 Unknown